Copolymer 1 acts against the immunodominant epitope 82–100 of myelin basic protein by T cell receptor antagonism in addition to major histocompatibility complex blocking
Data up to Jan 2025
Total Citations Per Year
Abstract
References (40)
Copolymer 1 reduces relapse rate and improves disability in relapsing‐remitting multiple sclerosis
1995 • 1,903 citations
Peptides Presented to the Immune System by the Murine Class II Major Histocompatibility Complex Molecule I-A d
1992 • 654 citations
Transmission of Signals from the T Lymphocyte Antigen Receptor to the Genes Responsible for Cell Proliferation and Immune Function: The Missing Link
1990 • 517 citations
Automated Synthesis of Peptides
1965 • 516 citations
Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor
1992 • 501 citations
Suppression of experimental allergic encephalomyelitis by a synthetic polypeptide
1971 • 431 citations
An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis
1995 • 422 citations
Tickling the TCR: selective T-cell functions stimulated by altered peptide ligands
1993 • 414 citations
Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapy
1989 • 394 citations
Molecular Events Mediating T Cell Activation
1990 • 303 citations
Copolymer 1 induces T cells of the T helper type 2 that crossreact with myelin basic protein and suppress experimental autoimmune encephalomyelitis
1997 • 280 citations
Direct binding of myelin basic protein and synthetic copolymer 1 to class II major histocompatibility complex molecules on living antigen-presenting cells--specificity and promiscuity.
1994 • 243 citations
T cell recognition as the target for immune intervention in autoimmune disease
1989 • 218 citations
Reversal of experimental autoimmune encephalomyelitis by a soluble peptide variant of a myelin basic protein epitope: T cell receptor antagonism and reduction of interferon gamma and tumor necrosis factor alpha production.
1994 • 216 citations
A single TCR antagonist peptide inhibits experimental allergic encephalomyelitis mediated by a diverse T cell repertoire.
1994 • 216 citations
Antigen Analogs/MHC Complexes as Specific T Cell Receptor Antagonists
1994 • 195 citations
Bystander suppression of experimental autoimmune encephalomyelitis by T cell lines and clones of the Th2 type induced by copolymer 1
1998 • 176 citations
A single amino acid change in a myelin basic protein peptide confers the capacity to prevent rather than induce experimental autoimmune encephalomyelitis.
1991 • 165 citations
A T cell receptor antagonist peptide induces T cells that mediate bystander suppression and prevent autoimmune encephalomyelitis induced with multiple myelin antigens
1997 • 158 citations
Copolymer 1 inhibits chronic relapsing experimental allergic encephalomyelitis induced by proteolipid protein (PLP) peptides in mice and interferes with PLP-specific T cell responses
1996 • 155 citations
Prevention of experimental encephalomyelitis with peptides that block interaction of T cells with major histocompatibility complex proteins.
1989 • 135 citations
Amelioration of relapsing experimental autoimmune encephalomyelitis with altered myelin basic protein peptides involves different cellular mechanisms
1997 • 120 citations
Inhibition of experimental autoimmune encephalomyelitis induction in SJL/J mice by using a peptide with high affinity for IAs molecules.
1990 • 118 citations
Specific inhibition of the T-cell response to myelin basic protein by the synthetic copolymer Cop 1.
1988 • 115 citations
Synthetic copolymer 1 inhibits human T-cell lines specific for myelin basic protein.
1992 • 111 citations
Promiscuous Binding of Synthetic Copolymer 1 to Purified HLA-DR Molecules
1998 • 111 citations
TCR usage in human and experimental demyelinating disease
1996 • 104 citations
In vivo and in vitro immunological cross‐reactions between basic encephalitogen and synthetic basic polypeptides capable of suppressing experimental allergic encephalomyelitis
1973 • 103 citations
Basic encephalitogenic protein: A simplified purification on sulphoethyl‐sephadex
1970 • 99 citations
Characterization of the immune response to a secondary encephalitogenic epitope of basic protein in Lewis rats. II. Biased T cell receptor V beta expression predominates in spinal cord infiltrating T cells.
1992 • 94 citations
Immunomodulation of experimental allergic encephalomyelitis by antibodies to the antigen–Ia complex
1991 • 92 citations
T suppressor hybridomas and interleukin‐2‐dependent lines induced by copolymer 1 or by spinal cord homogenate down‐regulate experimental allergic encephalomyelitis
1993 • 88 citations
Cross-reactions and specificities of monoclonal antibodies against myelin basic protein and against the synthetic copolymer 1.
1991 • 82 citations
Molecular requirements involved in suppression of eae by synthetic basic copolymers of amino acids
1976 • 66 citations
Major T-cell responses in multiple sclerosis
1995 • 52 citations
High affinity for class II molecules as a necessary but not sufficient characteristic of encephalitogenic determinants
1992 • 39 citations
Effect of conformational propensity of peptide antigens in their interaction with MHC class II molecules. Failure to document the importance of regular secondary structures.
1989 • 32 citations
T cell recognition motifs of an immunodominant peptide of myelin basic protein in patients with multiple sclerosis: structural requirements and clinical implications
1998 • 31 citations
Antigen Recognition and Peptide‐Mediated Immunotherapy in Autoimmune Disease
1990 • 30 citations
Selective immunosuppression of class II-restricted T cells by MHC class II-binding peptides.
1993 • 17 citations